Novartis signs $170 million immuno-oncology pact with Surface

ZURICH (Reuters) - Novartis AG has struck a $170 million alliance with U.S.-based Surface Oncology as it seeks to boost its portfolio of medicines that help the body's immune system fight cancer.

http://ift.tt/1Po6kbg

from Reuters: Health News
via animenewspro